LaserAway explores sale at valuation over 2 billion dollars
The Los Angeles-based medical spa chain LaserAway is working with investment bank Harris Williams to explore a potential sale. Backed by Ares Management and Seidler Equity Partners, the company generates approximately 150 million dollars in annual EBITDA and operates over 200 locations.
Insights:
LaserAway is exploring a sale that could value the medical spa chain at more than $2B. The Los Angeles-based provider generates approximately $150M in annual EBITDA across 219 locations. This potential transaction highlights the growing private equity appetite for medical aesthetics businesses that offer high recurring revenue through repeat treatments.
